GGrantIndex
← Leaderboards

Marc I Diamond

Ut Southwestern Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$15,957,069
Attributed
$23,222,547
Total exposure
16
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5M · FY2006–25
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,222,547 · 16

By mechanism

R01$13,565,563 · 7
RF1$6,686,691 · 2
R21$1,757,342 · 4
P30$538,799 · 1
R25$436,012 · 1
K08$238,140 · 1

Top collaborators

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Neurodegenerative Disorders”

Research focus

Neurodegenerative DisordersCellsAlzheimer&AposProteinsS DiseaseIn VivoPathologyMouse ModelBaseNeuronsTauopathiesMediatingBrainTau ProteinsTau AggregationGrantLeadIn VitroCell ModelStructureMolecularFluorescence Resonance Energy TransferGenesNerve Degeneration

Grant awards (52)

Mechanism of cell uptake for pathogenic tau seeds$666,475
R01 · FY2025 · AG · contact PI
North Texas ADRC - Biomarker Core$538,799
P30 · FY2025 · AG · contact PI
Seeds and Strains Derived from Tau Monomer$767,180
R01 · FY2024 · AG · contact PI
Mechanism of cell uptake for pathogenic tau seeds$680,077
R01 · FY2024 · AG · contact PI
Mechanism of cell uptake for pathogenic tau seeds$680,077
R01 · FY2023 · AG · contact PI
UT Southwestern Advancement of Neuroscience Research Careers (UT SWANS)$1
R25 · FY2023 · NS
Mechanism of cell uptake for pathogenic tau seeds$680,077
R01 · FY2022 · AG · contact PI
UT Southwestern Advancement of Neuroscience Research Careers (UT SWANS)$1
R25 · FY2022 · NS
UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers$88,369
R25 · FY2021 · NS · contact PI
Seeds and Strains Derived from Tau Monomer - Perez Diversity Supplement$64,690
RF1 · FY2021 · AG · contact PI
Seeds and Strains Derived from Tau Monomer$3,179,511
RF1 · FY2020 · AG · contact PI
Mechanism of modulation of huntingtin exon 1 aggregation by profilin$546,170
R01 · FY2020 · NS
APEX2-mediated Identification of factors involved in seeding by tau protein$449,333
R21 · FY2020 · AG · contact PI
A droplet microfluidics approach to measuring protein aggregation$202,500
R21 · FY2020 · AG · contact PI
UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers$88,368
R25 · FY2020 · NS · contact PI
Identification and characterization of tau seeding and strain composition in tauopathy$3,442,490
RF1 · FY2019 · AG · contact PI
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES$652,597
R01 · FY2019 · AG · contact PI
Mechanism of modulation of huntingtin exon 1 aggregation by profilin$559,073
R01 · FY2019 · NS
A droplet microfluidics approach to measuring protein aggregation$243,000
R21 · FY2019 · AG · contact PI
UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers$86,340
R25 · FY2019 · NS · contact PI
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES$655,219
R01 · FY2018 · AG · contact PI
Mechanism of modulation of huntingtin exon 1 aggregation by profilin$563,447
R01 · FY2018 · NS
UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers$91,624
R25 · FY2018 · NS · contact PI
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES$73,721
R01 · FY2018 · AG · contact PI
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES$654,953
R01 · FY2017 · AG · contact PI
Mechanism of modulation of huntingtin exon 1 aggregation by profilin$570,585
R01 · FY2017 · NS
UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers$81,309
R25 · FY2017 · NS · contact PI
Mechanism of modulation of huntingtin exon 1 aggregation by profilin$605,543
R01 · FY2016 · NS
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES$578,134
R01 · FY2016 · AG · contact PI
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES$76,343
R01 · FY2016 · AG · contact PI
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES$593,025
R01 · FY2015 · AG · contact PI
CELL-CELL TRANSFER AND PROPAGATION OF TAU AGGREGATES$182,400
R01 · FY2014 · NS · contact PI
CELL-CELL TRANSFER AND PROPAGATION OF TAU AGGREGATES$140,191
R01 · FY2014 · NS · contact PI
CELL-CELL TRANSFER AND PROPAGATION OF TAU AGGREGATES$314,445
R01 · FY2013 · NS · contact PI
CELL-CELL TRANSFER AND PROPAGATION OF TAU AGGREGATES$325,850
R01 · FY2012 · NS · contact PI
DEVELOPING A MOUSE RETINAL MODEL OF NEURODEGENERATIVE DISEASE$190,000
R21 · FY2012 · NS · contact PI
CELL-CELL TRANSFER AND PROPAGATION OF TAU AGGREGATES$325,850
R01 · FY2011 · NS · contact PI
DEVELOPING A MOUSE RETINAL MODEL OF NEURODEGENERATIVE DISEASE$190,000
R21 · FY2011 · NS · contact PI
CELL-CELL TRANSFER AND PROPAGATION OF TAU AGGREGATES$332,500
R01 · FY2010 · NS · contact PI
Efficacy and Mechanism of Novel Androgen Receptor Inhibitors$315,400
R01 · FY2010 · CA · contact PI
Regulation of Polyglutamine Aggregation and Toxicity$321,468
R01 · FY2009 · NS · contact PI
Efficacy and Mechanism of Novel Androgen Receptor Inhibitors$320,588
R01 · FY2009 · CA · contact PI
Regulation of Polyglutamine Aggregation and Toxicity$24,000
R01 · FY2009 · NS · contact PI
Regulation of Polyglutamine Aggregation and Toxicity$344,914
R01 · FY2008 · NS · contact PI
Efficacy and Mechanism of Novel Androgen Receptor Inhibitors$320,241
R01 · FY2008 · CA · contact PI
Regulation of Polyglutamine Aggregation and Toxicity$343,805
R01 · FY2007 · NS · contact PI
Regulation of Polyglutamine Aggregation and Toxicity$351,215
R01 · FY2006 · NS · contact PI
Cell and Molecular Screens of Polyglutamine Toxicity$215,888
R21 · FY2004 · NS
Cell and Molecular Screens of Polyglutamine Toxicity$75,750
R21 · FY2004 · NS
Cell and Molecular Screens of Polyglutamine Toxicity$190,871
R21 · FY2003 · NS
POLYGLUTAMINE-INDUCED NEURODEGENERATION IN SBMA$121,770
K08 · FY2001 · NS
POLYGLUTAMINE-INDUCED NEURODEGENERATION IN SBMA$116,370
K08 · FY2000 · NS